Charles Hennekens
Charles Hennekens
colleagues extreme fda quite surprised taken
My colleagues and I were quite surprised that the FDA has taken such an extreme position,
overall reaction
My overall reaction is that I'm pleased, because we need the data.
arteries basic higher levels processes reflected research role shown
Basic research has shown that in the arteries in the heart, that inflammatory processes that are reflected by higher levels of CRP may play a role in the development of hardening of the arteries or atherosclerosis,
acute almost heart patients percent recent survey
But there's still almost 30 percent of patients in a recent survey that weren't getting aspirin during an acute heart attack.
acute almost attack benefit best cost death far heart lower rate ratio risk second therapy
Those having a heart attack will have a far lower risk of having a second heart attack, a stroke, or their death rate is lowered almost a quarter. Aspirin has the best benefit to risk ratio and benefit to cost ratio of any therapy of acute heart attacks.